Acrivon Therapeutics, Inc. Common Stock (ACRV)
Who owns Acrivon Therapeutics, Inc. Common Stock (ACRV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 65.3% of the shares are freely tradable; institutional investors hold 47.4%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 19.49 | 8,340,508 | +0.0 | 03/31/2026 |
| Sands Capital Ventures, LLC | 4.96 | 2,122,605 | +0.0 | 03/31/2026 |
| Wellington Management Company LLP | 2.08 | 888,130 | +0.0 | 03/31/2026 |
| Acadian Asset Management LLC | 1.98 | 845,973 | +175,778.0 | 03/31/2026 |
| Renaissance Technologies Corp | 1.77 | 758,440 | +19.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 1.69 | 722,035 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 1.63 | 698,857 | +11.6 | 12/31/2025 |
| Marshall Wace Asset Management Ltd | 1.31 | 560,436 | +13.0 | 03/31/2026 |
| Two Sigma Investments LLC | 0.91 | 389,395 | -33.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.27 | 545,541 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 21. Jul 2026 | Miller Mary | Chief Legal Officer | Sell | 573 | 1.76 | 1,008 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.